title: Inactivation of tautomerase activity of macrophage migration inhibitory factor by sulforaphane: a potential biomarker for anti-inflammatory intervention.
abstract: BACKGROUND
  Macrophage migration inhibitory factor (MIF), a proinflammatory cytokine with keto-enol tautomerase activity, rises rapidly in response to inflammation and is elevated in many chronic diseases. Isothiocyanates, such as sulforaphane from broccoli, are very potent inactivators of MIF tautomerase activity. A simple rapid method for determining this activity in tissues and body fluids may therefore be valuable for assessing severity of inflammation and efficacy of intervention.
  
  
  METHODS
  Existing spectrophotometric assays of MIF, based on conversion of methyl L-dopachrome to methyl 5,6-dihydroxyindole-2-carboxylate and associated loss of absorption at 475 nm, lack sensitivity. Assay sensitivity and efficiency were markedly improved by reducing the nonenzymatic rate, by lowering pH to 6.2, replacing phosphate (which catalyzes the reaction) with Bis-Tris buffer, and converting to a microtiter plate format.
  
  
  RESULTS
  A structure-potency study of MIF tautomerase inactivation by isothiocyanates showed that sulforaphane, benzyl, n-hexyl, and phenethyl isothiocyanates were especially potent. MIF tautomerase could be readily quantified in human urine concentrated by ultrafiltration. This activity comprised: (i) a heat-labile, sulforaphane-inactivated macromolecular fraction (presumably MIF) that was concentrated during ultrafiltration; (ii) a flow-through fraction, with constant activity during filtration, that was heat stable and insensitive to sulforaphane. Administration of the sulforaphane precursor glucoraphanin to human volunteers almost completely abolished urinary tautomerase activity, which recovered over many hours.
  
  
  CONCLUSIONS
  A simple, rapid, quantitative MIF tautomerase assay has been developed as a potential biomarker for assessing inflammatory severity and effectiveness of intervention.
  
  
  CONCLUSIONS
  An improved assay for measuring MIF tautomerase activity and its applications are described.
authors: The Lewis B. and Dorothy Cullman Cancer Chemoprotection Center, Department of Pharmacology and Molecular Sciences, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA.
authors: Zachary R
authors: ZR
authors: Healy
authors: Hua
authors: H
authors: Liu
authors: W David
authors: WD
authors: Holtzclaw
authors: Paul
authors: P
authors: Talalay
references: Annu Rev Pharmacol Toxicol. 2007;47:89-116
references: 16968214
references: J Med Chem. 2007 Apr 19;50(8):1993-7
references: 17385848
references: Biochemistry. 1996 Jan 23;35(3):814-23
references: 8547261
references: Biochemistry. 1999 Jun 1;38(22):7346-54
references: 10353846
references: Biochemistry. 1996 Jan 23;35(3):803-13
references: 8547260
references: Adv Enzyme Regul. 2003;43:121-34
references: 12791387
references: J Biol Chem. 2005 Nov 4;280(44):36541-4
references: 16115897
references: Crit Care Med. 2002 Jan;30(1 Supp):S27-S35
references: 11891404
references: Mol Cell Biol. 2009 Apr;29(7):1922-32
references: 19188446
references: FASEB J. 2010 Nov;24(11):4459-66
references: 20624927
references: Cell Mol Life Sci. 2008 Nov;65(22):3606-18
references: 18695941
references: Biochem Biophys Res Commun. 2011 Feb 4;405(1):146-51
references: 21219867
references: Drug News Perspect. 2010 May;23(4):257-64
references: 20520854
references: Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10367-72
references: 9294217
references: Arch Biochem Biophys. 2002 Jun 1;402(1):1-13
references: 12051677
references: Cancer Res. 2008 Sep 15;68(18):7253-7
references: 18794110
references: Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):144-9
references: 11773615
references: Protein Eng. 1996 Aug;9(8):631-5
references: 8875640
references: Nat Med. 2000 Feb;6(2):164-70
references: 10655104
references: Adv Enzyme Regul. 1984;22:27-55
references: 6382953
references: Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):501-8
references: 11352861
references: FEBS Lett. 1997 Nov 3;417(1):85-8
references: 9395080
references: J Exp Med. 1999 Jan 18;189(2):341-6
references: 9892616
references: Biochemistry. 2009 Oct 20;48(41):9858-70
references: 19737008
references: J Biol Chem. 2009 Nov 20;284(47):32425-33
references: 19776019
references: Anal Biochem. 1985 Oct;150(1):76-85
references: 3843705
references: Biochem J. 1991 Jul 15;277 ( Pt 2):393-7
references: 1859367
references: Biochemistry. 1997 Dec 9;36(49):15356-62
references: 9398265
references: Biochemistry. 1994 Nov 29;33(47):14144-55
references: 7947826
references: Trends Mol Med. 2004 Nov;10(11):549-57
references: 15519281
references: Biochem J. 2009 Oct 12;423(3):315-21
references: 19723024
references: Biofactors. 2009 Mar-Apr;35(2):165-8
references: 19322762
references: Mol Med. 1996 Jan;2(1):143-9
references: 8900542
references: Biochemistry. 1998 Jul 14;37(28):10195-202
references: 9665726
references: Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2399-403
references: 1549603
references: PLoS Pathog. 2010 Mar 26;6(3):e1000826
references: 20361053